These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32441433)

  • 1. Successful treatment of resistant pityriasis rubra pilaris with ixekizumab.
    Penalba-Torres M; Pinilla-Martín B; Aragón-Miguel R; Velasco-Tamariz V; Rivera-Díaz R
    Dermatol Ther; 2020 Jul; 33(4):e13644. PubMed ID: 32441433
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of Ixekizumab Treatment for Patients With Pityriasis Rubra Pilaris: A Single-Arm Trial.
    Haynes D; Strunck JL; Topham CA; Ortega-Loayza AG; Kent G; Cassidy PB; Hu R; Choate K; Wang Z; Liu Y; Greiling TM
    JAMA Dermatol; 2020 Jun; 156(6):668-675. PubMed ID: 32293641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of bullous pemphigoid developing after ixekizumab therapy for pityriasis rubra pilaris.
    Sugihara N; Kamiya K; Nakano N; Suzuki M; Maekawa T; Murata S; Komine M; Ohtsuki M
    J Dermatol; 2023 Jun; 50(6):e185-e186. PubMed ID: 36651010
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pityriasis rubra pilaris : Successful treatment with ixekizumab].
    Kohn D; Wetzig T
    Hautarzt; 2020 Aug; 71(8):624-626. PubMed ID: 32185430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of pityriasis rubra pilaris treated with tofacitinib after failure with acitretin and ixekizumab.
    Ying Y; Yu-Hua L; Xiao-Yan W; Su-Chun H
    Australas J Dermatol; 2023 Aug; 64(3):445-447. PubMed ID: 37200390
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful treatment of TNFα inhibitor-resistant pityriasis rubra pilaris with ixekizumab and acitretin.
    Chastagner M; Hoelt P; Kanitakis J; Jullien D; Villani AP
    Eur J Dermatol; 2019 Apr; 29(2):218-220. PubMed ID: 30827945
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of Pityriasis Rubra Pilaris With Guselkumab.
    Pilz AC; Seiringer P; Biedermann T; Eyerich K
    JAMA Dermatol; 2019 Dec; 155(12):1424-1426. PubMed ID: 31577328
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful treatment of pityriasis rubra pilaris with guselkumab: Serum CCL20 as a potential marker for the disease activity.
    Nagai H; Jimbo H; Matsuura S; Tatsuoka S; Shiraki E; Nishigori C
    Dermatol Ther; 2020 Nov; 33(6):e14403. PubMed ID: 33044038
    [No Abstract]   [Full Text] [Related]  

  • 9. Bimekizumab in refractory pityriasis rubra pilaris.
    Kromer C; Schön MP; Mössner R
    J Dtsch Dermatol Ges; 2024 Jan; 22(1):102-104. PubMed ID: 38066410
    [No Abstract]   [Full Text] [Related]  

  • 10. Pityriasis rubra pilaris: a review of diagnosis and treatment.
    Cohen PR; Prystowsky JH
    J Am Acad Dermatol; 1989 May; 20(5 Pt 1):801-7. PubMed ID: 2654219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of Pityriasis rubra pilaris with brodalumab.
    De Rosa A; Gambardella A; Licata G; Alfano R; Argenziano G
    Australas J Dermatol; 2020 May; 61(2):e249-e251. PubMed ID: 31851372
    [No Abstract]   [Full Text] [Related]  

  • 12. Pityriasis rubra pilaris: treatment with biologics - a new promising therapy?
    Ivanova K; Itin P; Haeusermann P
    Dermatology; 2012; 224(2):120-5. PubMed ID: 22508269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate treatment in a case of juvenile pityriasis rubra pilaris.
    Boyd AH; Polcari IC
    Pediatr Dermatol; 2018 Jan; 35(1):e62-e63. PubMed ID: 29044698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of pityriasis rubra pilaris with tildrakizumab.
    Zagarella SS; Jiang KW
    Australas J Dermatol; 2022 Feb; 63(1):120-121. PubMed ID: 34854479
    [No Abstract]   [Full Text] [Related]  

  • 15. A case of treatment-resistant pityriasis rubra pilaris responsive to secukinumab.
    Simpson K; Dolianitis C
    Australas J Dermatol; 2021 Aug; 62(3):441-442. PubMed ID: 34028789
    [No Abstract]   [Full Text] [Related]  

  • 16. Secukinumab monotherapy successfully treated severe refractory type V (atypical juvenile) pityriasis rubra pilaris: A case report and literature review.
    Liang JY; Ye RX; Tian X; Zhang SQ; Zhang XB
    Dermatol Ther; 2020 Nov; 33(6):e14097. PubMed ID: 32725719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pityriasis rubra pilaris and HIV infection.
    Blauvelt A; Nahass GT; Pardo RJ; Kerdel FA
    J Am Acad Dermatol; 1991 May; 24(5 Pt 1):703-5. PubMed ID: 1869640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pityriasis rubra pilaris heralding diagnosis of urothelial carcinoma: a case report.
    Young PA; Rangel J; Keller LC
    Dermatol Online J; 2022 Aug; 28(4):. PubMed ID: 36259857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical improvement of pityriasis rubra pilaris with efalizumab in a pediatric patient.
    Gómez M; Ruelas ME; Welsh O; Arcaute HD; Ocampo-Candiani J
    J Drugs Dermatol; 2007 Mar; 6(3):337-9. PubMed ID: 17373198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of pityriasis rubra pilaris with adalimumab - case report.
    Bravo EA; Carrion L; Paucar SM; Mendoza R; Rivera C
    Dermatol Online J; 2014 Apr; 20(4):22374. PubMed ID: 24746310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.